Pacific Biosciences Of California Current Ratio 2010-2025 | PACB

Pacific Biosciences Of California current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Pacific Biosciences Of California Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.45B $0.07B 6.68
2024-12-31 $0.50B $0.07B 7.48
2024-09-30 $0.58B $0.06B 9.74
2024-06-30 $0.63B $0.08B 8.01
2024-03-31 $0.68B $0.07B 9.28
2023-12-31 $0.74B $0.10B 7.81
2023-09-30 $0.88B $0.18B 4.80
2023-06-30 $0.94B $0.27B 3.45
2023-03-31 $0.98B $0.27B 3.69
2022-12-31 $0.85B $0.26B 3.24
2022-09-30 $0.91B $0.08B 11.19
2022-06-30 $0.97B $0.08B 11.50
2022-03-31 $1.03B $0.06B 16.87
2021-12-31 $1.10B $0.07B 15.36
2021-09-30 $1.13B $0.06B 20.32
2021-06-30 $1.19B $0.05B 26.17
2021-03-31 $1.20B $0.03B 35.45
2020-12-31 $0.36B $0.04B 9.24
2020-09-30 $0.24B $0.13B 1.84
2020-06-30 $0.15B $0.13B 1.15
2020-03-31 $0.17B $0.13B 1.29
2019-12-31 $0.08B $0.05B 1.65
2019-09-30 $0.08B $0.05B 1.52
2019-06-30 $0.10B $0.05B 2.00
2019-03-31 $0.11B $0.05B 2.50
2018-12-31 $0.13B $0.03B 4.90
2018-09-30 $0.14B $0.02B 6.65
2018-06-30 $0.10B $0.02B 4.33
2018-03-31 $0.12B $0.03B 4.64
2017-12-31 $0.10B $0.03B 3.55
2017-09-30 $0.11B $0.03B 3.75
2017-06-30 $0.13B $0.04B 3.72
2017-03-31 $0.09B $0.04B 2.49
2016-12-31 $0.11B $0.03B 3.23
2016-09-30 $0.12B $0.03B 3.81
2016-06-30 $0.14B $0.03B 4.08
2016-03-31 $0.12B $0.03B 3.72
2015-12-31 $0.11B $0.04B 2.90
2015-09-30 $0.09B $0.04B 2.22
2015-06-30 $0.09B $0.04B 2.31
2015-03-31 $0.10B $0.04B 2.59
2014-12-31 $0.12B $0.03B 3.74
2014-09-30 $0.11B $0.03B 3.92
2014-06-30 $0.12B $0.03B 4.29
2014-03-31 $0.13B $0.02B 5.87
2013-12-31 $0.13B $0.02B 5.61
2013-09-30 $0.14B $0.02B 6.31
2013-06-30 $0.12B $0.02B 8.09
2013-03-31 $0.13B $0.01B 9.31
2012-12-31 $0.12B $0.02B 7.80
2012-09-30 $0.13B $0.01B 9.71
2012-06-30 $0.15B $0.02B 10.23
2012-03-31 $0.18B $0.02B 8.93
2011-12-31 $0.20B $0.02B 10.30
2011-09-30 $0.22B $0.02B 10.42
2011-06-30 $0.25B $0.02B 11.40
2011-03-31 $0.26B $0.02B 10.95
2010-12-31 $0.29B $0.02B 14.07
2010-09-30 $0.12B $0.02B 5.12
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.381B $0.154B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $182.564B 79.96
Thermo Fisher Scientific (TMO) United States $150.197B 18.17
Edwards Lifesciences (EW) United States $43.309B 28.40
IDEXX Laboratories (IDXX) United States $42.135B 48.42
Alcon (ALC) Switzerland $42.123B 28.47
DexCom (DXCM) United States $31.369B 48.48
IQVIA Holdings (IQV) United States $26.768B 14.99
Mettler-Toledo (MTD) United States $23.982B 28.52
STERIS (STE) Ireland $23.183B 25.53
Waters (WAT) United States $20.390B 28.77
SONOVA HOLDING (SONVY) Switzerland $17.638B 0.00
Hologic (HOLX) United States $14.369B 15.61
Sysmex ADR (SSMXY) Japan $10.550B 29.93
Penumbra (PEN) United States $9.948B 78.08
Masimo (MASI) United States $8.956B 33.04
Globus Medical (GMED) United States $7.834B 18.67
Glaukos (GKOS) United States $5.723B 0.00
Teleflex (TFX) United States $5.228B 8.63
TransMedics (TMDX) United States $4.179B 90.85
Integer Holdings (ITGR) United States $4.110B 21.54
PROCEPT BioRobotics (PRCT) United States $3.332B 0.00
LivaNova (LIVN) United Kingdom $2.481B 14.78
Nihon Kohden (NHNKY) Japan $2.265B 25.98
Veracyte (VCYT) United States $2.067B 29.00
Elekta AB (EKTAY) Sweden $1.901B 17.09
Alphatec Holdings (ATEC) United States $1.599B 0.00
Tandem Diabetes Care (TNDM) United States $1.347B 0.00
Artivion (AORT) United States $1.292B 121.00
Pulse Biosciences (PLSE) United States $1.029B 0.00
OPKO Health (OPK) United States $1.023B 0.00
Integra LifeSciences Holdings (IART) United States $0.901B 4.79
Beta Bionics (BBNX) United States $0.776B 0.00
IRadimed (IRMD) United States $0.741B 37.57
SiBone (SIBN) United States $0.698B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.561B 8.73
RxSight (RXST) United States $0.553B 0.00
Mesa Laboratories (MLAB) United States $0.523B 12.25
OrthoPediatrics (KIDS) United States $0.493B 0.00
Delcath Systems (DCTH) United States $0.482B 0.00
AxoGen (AXGN) United States $0.443B 0.00
AngioDynamics (ANGO) United States $0.407B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.405B 0.00
Semler Scientific (SMLR) United States $0.403B 10.72
Treace Medical Concepts (TMCI) United States $0.347B 0.00
NeuroPace (NPCE) United States $0.341B 0.00
ClearPoint Neuro (CLPT) United States $0.315B 0.00
908 Devices (MASS) United States $0.263B 0.00
Tactile Systems Technology (TCMD) United States $0.232B 14.04
Neuronetics (STIM) United States $0.228B 0.00
Sight Sciences (SGHT) United States $0.210B 0.00
Alpha Tau Medical (DRTS) Israel $0.204B 0.00
Biosig Technologies (BSGM) United States $0.183B 0.00
Inogen (INGN) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
CVRx (CVRX) United States $0.153B 0.00
Anteris Technologies Global (AVR) Australia $0.147B 0.00
LENSAR (LNSR) United States $0.146B 0.00
Rapid Micro Biosystems (RPID) United States $0.146B 0.00
Lucid Diagnostics (LUCD) United States $0.136B 0.00
Accuray (ARAY) United States $0.126B 0.00
Atossa Genetics (ATOS) United States $0.102B 0.00
Monogram Orthopaedics (MGRM) United States $0.100B 0.00
Microbot Medical (MBOT) United States $0.088B 0.00
Sensus Healthcare (SRTS) United States $0.078B 47.30
InspireMD (NSPR) United States $0.075B 0.00
EnVVeno Medical (NVNO) United States $0.071B 0.00
EDAP TMS S.A (EDAP) France $0.063B 0.00
Spectral AI (MDAI) United States $0.055B 0.00
Hyperfine (HYPR) United States $0.054B 0.00
Positron (POSC) United States $0.050B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Baird Medical Investment Holdings (BDMD) $0.043B 0.00
Precision Optics (POCI) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
NexGel (NXGL) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Ekso Bionics Holdings (EKSO) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.32